Despite the availability of numerous treatment options, chemotherapy induced nausea and vomiting (CINV) remains an important problem for both clinicians and patients. This interactive symposium will provide oncology nurses with information that will help them to better evaluate patient-specific and chemotherapy-specific risk factors associated with CINV, differentiate among available treatment options, assess emerging approaches for CINV prevention and management, formulate the optimal treatment plan for CINV prophylaxis, and summarize safety concerns associated with anti-emetogenic agents.
This activity is supported by an unrestricted educational grant provided by Heron Therapeutics
